標(biāo)題: Titlebook: Recombinant Antibodies for Infectious Diseases; Theam Soon Lim Book 2017 Springer International Publishing AG, part of Springer Nature 201 [打印本頁(yè)] 作者: Diverticulum 時(shí)間: 2025-3-21 18:51
書(shū)目名稱(chēng)Recombinant Antibodies for Infectious Diseases影響因子(影響力)
書(shū)目名稱(chēng)Recombinant Antibodies for Infectious Diseases影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Recombinant Antibodies for Infectious Diseases網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Recombinant Antibodies for Infectious Diseases網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Recombinant Antibodies for Infectious Diseases被引頻次
書(shū)目名稱(chēng)Recombinant Antibodies for Infectious Diseases被引頻次學(xué)科排名
書(shū)目名稱(chēng)Recombinant Antibodies for Infectious Diseases年度引用
書(shū)目名稱(chēng)Recombinant Antibodies for Infectious Diseases年度引用學(xué)科排名
書(shū)目名稱(chēng)Recombinant Antibodies for Infectious Diseases讀者反饋
書(shū)目名稱(chēng)Recombinant Antibodies for Infectious Diseases讀者反饋學(xué)科排名
作者: Exaggerate 時(shí)間: 2025-3-21 22:21 作者: echnic 時(shí)間: 2025-3-22 04:26 作者: 愉快嗎 時(shí)間: 2025-3-22 07:21
Luiz R. Goulart,Vanessa da S. Ribeiro,Julia M. Costa-Cruzd ihrer artspezifischen Veranlagung auf einen bestimmten SO.-Gehalt reagieren und in welchem Ma?e Sch?digungen w?hrend vegetativer oder generativer Wachstumsphasen den Nutzungswert der Kulturen beeintr?chtigen. So mu? die Beziehung zwischen der Sch?digung und dem Schauen bekannt sein, wenn sp?ter di作者: 熟練 時(shí)間: 2025-3-22 09:33 作者: compassion 時(shí)間: 2025-3-22 15:39
Gaowei Fan,Jinming Liührt wurden, erhebt sich die Frage, ob auch akute Versuche als vergleichbar herangezogen werden k?nnen, sei es Versuche mit chemischen oder elektrischen Reizen. Dies scheint nicht ohne weiteres angebracht; solche Experimente erfassen einen v?llig anderen Aspekt epileptischer Reaktionen, ganz abgeseh作者: 戲法 時(shí)間: 2025-3-22 17:55 作者: macular-edema 時(shí)間: 2025-3-22 22:50
Felix Breden,Corey T. Watsonung der Pflanzenarten nach ihrer HF-Resistenz in Form von Resistenzreihen oder Resistenzgruppen ist sowohl für die Diagnostik als auch für den Anbau von Pflanzen in Gebieten mit HF-Immissionen von Bedeutung. Die Stellung einer Pflanzenart innerhalb einer Resistenzreihe kann sich aber mit den Kriteri作者: 共同時(shí)代 時(shí)間: 2025-3-23 02:39
Adam Seidelin Heyrüchlich: von den meist ?lteren Autoren wurde festgestellt, da? sich die Kapillaren beim Durchtritt durch die Bowmansche Kapsel teilen, ein Gef??kn?uel bilden und ohne innerhalb des Glomerulum Verbindungen (Anastomosen) untereinander einzugehen, sich bei ihrem Austritt am Vas efferens wieder vereini作者: charisma 時(shí)間: 2025-3-23 07:26 作者: 治愈 時(shí)間: 2025-3-23 11:05
Engineering Antibodies for the Treatment of Infectious Diseases, The advancement of antibody engineering technologies has made it feasible to generate monoclonal antibodies. There are divergent methods for antibody engineering and optimization. In this chapter, we summarized the latest developments in engineering antibodies for infectious diseases.作者: 靈敏 時(shí)間: 2025-3-23 13:54
Computer-Aided Antibody Design: An Overview,to design molecules for optimizing affinity, better efficacy, greater safety and therapeutic function. Therefore, computational methods have become increasingly important to generate hypotheses, interpret and guide experimental works. In this chapter, we discussed the overall antibody design by computational approches.作者: 正常 時(shí)間: 2025-3-23 21:44
Advances in Experimental Medicine and Biologyhttp://image.papertrans.cn/r/image/824085.jpg作者: ineffectual 時(shí)間: 2025-3-23 23:31
https://doi.org/10.1007/978-3-319-72077-7Antibody Phage Display; Antibody Library; Synthetic Antibody; Immunized Antibody; Infectious Diseases; an作者: 邪惡的你 時(shí)間: 2025-3-24 02:28 作者: insurgent 時(shí)間: 2025-3-24 07:45 作者: 法律 時(shí)間: 2025-3-24 11:00 作者: 賠償 時(shí)間: 2025-3-24 16:21 作者: 高歌 時(shí)間: 2025-3-24 21:31
Synthetic Antibodies in Infectious Disease,ombinant antibody library technology with an emphasis on our work using a highly successful synthetic single framework Fab library. We demonstrate its utility in targeting viruses and bacterial toxins in five case studies.作者: filicide 時(shí)間: 2025-3-25 00:10 作者: Physiatrist 時(shí)間: 2025-3-25 04:10 作者: 撫育 時(shí)間: 2025-3-25 10:28
Filamentous Phage: Structure and Biology,riophage in display technology stems from the titres that are about 100-fold higher than any other known phage, efficacious transformation ensuring large library size and superior stability of the virion at high temperatures, detergents and pH extremes, allowing broad range of biopanning conditions 作者: Factual 時(shí)間: 2025-3-25 12:38 作者: Notorious 時(shí)間: 2025-3-25 17:45
,Na?ve Human Antibody Libraries for Infectious Diseases,lem as it facilitates the re-emergence of old infectious diseases as well as promote the introduction of new and more deadly variants. Evidently, infectious diseases have contributed to an alarming rate of mortality worldwide making it a growing concern. Historically, antibodies have been used succe作者: 笨重 時(shí)間: 2025-3-25 21:54
Immune Human Antibody Libraries for Infectious Diseases,ns. Historically, antiserum produced from immunised horses have been used to treat diphtheria. Despite the potential of antiserum, the economical and medial concerns associated with the use of animal antiserum has led to its slow market demise. Over the years, new and emerging infectious diseases ha作者: 小步舞 時(shí)間: 2025-3-26 03:33
Synthetic Antibodies in Infectious Disease,eases. Synthetic antibody libraries displayed on phage offer unique advantages over traditional immunization-based antibody generation, including full control over library design and selection conditions. The technology has matured beyond natural antibodies and is capable of providing novel insights作者: Antagonist 時(shí)間: 2025-3-26 07:22
Monoclonal Antibodies and Antibody Like Fragments Derived from Immunised Phage Display Libraries,evitable, but unpredictable emergence of new infectious diseases has become a global threat. HIV/AIDS, severe acute respiratory syndrome (SARS), and the more recent H1N1 influenza are only a few of the numerous examples of emerging infectious diseases in the modern era. However despite advances in d作者: 無(wú)力更進(jìn) 時(shí)間: 2025-3-26 11:15 作者: nitric-oxide 時(shí)間: 2025-3-26 14:23
Anti-parasitic Antibodies from Phage Display,but such diseases are still neglected in endemic countries. Therapeutic interventions consisted mostly of drugs, which are highly toxic and may lead to resistance. The immunopathology of parasites is very complex due to their multistage life cycles and long lifetime involving several hosts, leading 作者: 摘要 時(shí)間: 2025-3-26 18:15
Therapeutic Antibodies for Biodefense,ntionally disseminated in the environment by a State (military context) or terrorists to cause diseases in a population or livestock, to destabilize a nation by creating a climate of terror, destabilizing the economy and undermining institutions. Biological agents can be classified according to the 作者: Generic-Drug 時(shí)間: 2025-3-26 22:24 作者: 討人喜歡 時(shí)間: 2025-3-27 03:59
Computer-Aided Antibody Design: An Overview,to design molecules for optimizing affinity, better efficacy, greater safety and therapeutic function. Therefore, computational methods have become increasingly important to generate hypotheses, interpret and guide experimental works. In this chapter, we discussed the overall antibody design by comp作者: Colonoscopy 時(shí)間: 2025-3-27 06:56
Using High-Throughput Sequencing to Characterize the Development of the Antibody Repertoire During a sets have already become critical to the design of vaccines and therapeutics, and monitoring of cancer immunotherapy. As a case study, we describe the potential and present limitations of HTS studies of the Ab repertoire during infection with HIV-1. Most of the present studies restrict their analy作者: 價(jià)值在貶值 時(shí)間: 2025-3-27 12:09 作者: 陶醉 時(shí)間: 2025-3-27 14:02
Using High-Throughput Sequencing to Characterize the Development of the Antibody Repertoire During ses to lineages of specific bnAbs. We discuss future initiatives to expand this type of analysis to more complete repertoires and to improve comparing and sharing of these Ab repertoire data across studies and institutions.作者: Baffle 時(shí)間: 2025-3-27 20:31 作者: 馬具 時(shí)間: 2025-3-28 01:04 作者: 動(dòng)物 時(shí)間: 2025-3-28 02:10 作者: Ccu106 時(shí)間: 2025-3-28 08:33
Jasna Rakonjac,Marjorie Russel,Sofia Khanum,Sam J. Brooke,Marina Raji?ge anatomische Kontrolle der ausgeführten Operationen notwendig ist, wenn man daraus lokalisatorische Schlüsse ziehen will, und ich habe daher in einer Reihe von F?llen Frontalserien angelegt, um den wirklichen Umfang der Operationen genau zu bestimmen; auch durch Heranziehung der Ergebnisse der zyt作者: Ceremony 時(shí)間: 2025-3-28 12:53
Hyunbo Shimge anatomische Kontrolle der ausgeführten Operationen notwendig ist, wenn man daraus lokalisatorische Schlüsse ziehen will, und ich habe daher in einer Reihe von F?llen Frontalserien angelegt, um den wirklichen Umfang der Operationen genau zu bestimmen; auch durch Heranziehung der Ergebnisse der zyt作者: 影響 時(shí)間: 2025-3-28 16:20
Eszter Nagy,Gábor Nagy,Christine A. Power,Adriana Badarau,Valéria Szijártól der Befruchtung, so ist eine direkte Beurteilung m?glich. In den meisten F?llen kann man aber nicht ohne weiteres von einer Momentansch?digung auf den Endschaden schlie?en. So ist es beispielsweise schwierig, von Blattsch?digungen, die zu irgendeiner Wachstumsperiode an Getreidepflanzen auftreten,作者: 小卷發(fā) 時(shí)間: 2025-3-28 21:36 作者: 治愈 時(shí)間: 2025-3-29 00:11
Arnaud Avril.]) vorliegt. . [.] teilte kurz mit, da? chronische Ableitungen am Kaninchen den in den akuten Versuchsphasen durchgeführten entsprechen sollen. Auch die Versuche dieses Autors, die zwar mit chronischen Pr?paraten durchgeführt wurden, sind kaum den vorliegenden vergleichbar. Die Tiere n?mlich wurden作者: Chipmunk 時(shí)間: 2025-3-29 04:29
Gaowei Fan,Jinming Li.]) vorliegt. . [.] teilte kurz mit, da? chronische Ableitungen am Kaninchen den in den akuten Versuchsphasen durchgeführten entsprechen sollen. Auch die Versuche dieses Autors, die zwar mit chronischen Pr?paraten durchgeführt wurden, sind kaum den vorliegenden vergleichbar. Die Tiere n?mlich wurden作者: Abominate 時(shí)間: 2025-3-29 09:47
Yee Siew Choong,Yie Vern Lee,Jia Xin Soong,Cheh Tat Law,Yee Ying Lim?s?ure geleitet, die sich in thermostatisierten Kunststoffbeh?ltern befindet. Die vorbeistr?mende Tr?gerluft bel?dt sich dabei entsprechend dem HF-Partialdruck über der Flu?s?ure mit Fluorwasserstoff. Durch Variieren von Temperatur und Konzentration der Flu?s?ure sowie des Luftdurchsatzes l??t sich 作者: 窒息 時(shí)間: 2025-3-29 12:08 作者: 沖突 時(shí)間: 2025-3-29 15:44 作者: cultivated 時(shí)間: 2025-3-29 21:16 作者: BOON 時(shí)間: 2025-3-30 01:22
Soo Khim Chan,Anizah Rahumatullah,Jing Yi Lai,Theam Soon Lim作者: Judicious 時(shí)間: 2025-3-30 05:49
0065-2598 engineering in the context of infectious disease will also help to provide greater insight to the potential of recombinant antibodies for infectious diseases..978-3-030-10153-4978-3-319-72077-7Series ISSN 0065-2598 Series E-ISSN 2214-8019 作者: 明確 時(shí)間: 2025-3-30 10:11
,Na?ve Human Antibody Libraries for Infectious Diseases,tibody libraries should not be underestimated. The na?ve repertoire has its own unique advantages in generating antibodies against target antigens. This chapter will highlight the concept, advantages and application of human na?ve libraries as a source to isolate antibodies against infectious diseas作者: 牢騷 時(shí)間: 2025-3-30 12:25 作者: saphenous-vein 時(shí)間: 2025-3-30 16:35 作者: 甜瓜 時(shí)間: 2025-3-30 23:43 作者: voluble 時(shí)間: 2025-3-31 01:12
Therapeutic Antibodies for Biodefense,apeutic properties, act fast and are highly specific to the target. This review focuses on the main biological agents that could be used as bioweapons, the history of biowarfare and antibodies that have been developed to neutralize these agents.作者: 愚蠢人 時(shí)間: 2025-3-31 07:43
Safety and General Considerations for the Use of Antibodies in Infectious Diseases,pport their clinical development. Special considerations for anti-infective mAb treatments are provided including the special features that makes nonclinical safety programs for anti-infective mAbs much more simple and restricted. However at a cost since only limited information for clinical safety
